Skip to main content
# Title Department Research Member Research Year
61 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute Department of Pediatric Oncology Dr. Shimaa Hassan Shabaan Hassan 2022
62 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Neveen Abdelazeem Abdelraheem 2022
63 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2022
64 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2022
65 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2022
66 Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone Department of Clinical Pathology Dr. Noha gaber sayed 2022
67 The Advantage of Drug-Eluting Trans-Arterial Chemo-embolization Over The Conventional Technique in The Management of Hepatocellular Carcinoma (Bi-Institutional Study) Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2022
68 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Samar Muhammad mansour 2022
69 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt Department of Pediatric Oncology Prof. Douaa Mohamed Sayed Hussein 2022
70 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Hanaan Ahmed Mohammed Ahmed 2022